C. B. Granger

584 total citations
23 papers, 324 citations indexed

About

C. B. Granger is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C. B. Granger has authored 23 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 6 papers in Economics and Econometrics and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C. B. Granger's work include Atrial Fibrillation Management and Outcomes (11 papers), Acute Myocardial Infarction Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). C. B. Granger is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Acute Myocardial Infarction Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). C. B. Granger collaborates with scholars based in United States, Sweden and Canada. C. B. Granger's co-authors include Salim Yusuf, John J.V. McMurray, Robert M. Califf, Mark N. Feinglos, Bradley A. Bart, Georg Ertl, Karl Swedberg, James B. Young, J Kuch and Aldo P. Maggioni and has published in prestigious journals such as European Heart Journal, American Heart Journal and Journal of Internal Medicine.

In The Last Decade

C. B. Granger

22 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. B. Granger United States	7	280	43	43	38	35	23	324
Akihiro Sunaga Japan	10	376 1.3×	46 1.1×	51 1.2×	59 1.6×	42 1.2×	45	445
Mustafa Soylu Türkiye	11	261 0.9×	34 0.8×	25 0.6×	67 1.8×	47 1.3×	38	363
Israel Freeman United States	6	500 1.8×	74 1.7×	20 0.5×	74 1.9×	46 1.3×	7	566
Yasunori Kanzaki Japan	13	306 1.1×	47 1.1×	16 0.4×	58 1.5×	17 0.5×	58	402
Tushar Acharya United States	11	212 0.8×	46 1.1×	51 1.2×	72 1.9×	36 1.0×	30	332
Hirota Kida Japan	9	258 0.9×	46 1.1×	50 1.2×	58 1.5×	32 0.9×	32	322
Selim Ayhan Türkiye	13	267 1.0×	37 0.9×	20 0.5×	54 1.4×	55 1.6×	23	356
Pascal Meyre Switzerland	11	316 1.1×	38 0.9×	25 0.6×	55 1.4×	24 0.7×	33	405
Ruka Yoshida Japan	11	197 0.7×	62 1.4×	13 0.3×	83 2.2×	26 0.7×	38	272
Mattheus Ramsis United States	7	239 0.9×	50 1.2×	21 0.5×	71 1.9×	19 0.5×	14	334

Countries citing papers authored by C. B. Granger

Since Specialization

Citations

This map shows the geographic impact of C. B. Granger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. B. Granger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. B. Granger more than expected).

Fields of papers citing papers by C. B. Granger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. B. Granger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. B. Granger. The network helps show where C. B. Granger may publish in the future.

Co-authorship network of co-authors of C. B. Granger

This figure shows the co-authorship network connecting the top 25 collaborators of C. B. Granger. A scholar is included among the top collaborators of C. B. Granger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. B. Granger. C. B. Granger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Røsjø, Helge, Ziad Hijazi, Torbjørn Omland, et al.. (2020). Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. Journal of Internal Medicine. 288(2). 248–259. 4 indexed citations

Hijazi, Ziad, Jonas Oldgren, Johan Lindbäck, et al.. (2017). 5770A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials. European Heart Journal. 38(suppl_1). 3 indexed citations

Hanna, Michael G., Lars Wallentin, James Alexander, et al.. (2016). Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin : insights from the ARISTOTLE trial. 37. 507–507. 2 indexed citations

Rordorf, Roberto, Gaetano Maria De Ferrari, Daniel Wojdyla, et al.. (2015). Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure : insights from the ARISTOTLE trial. European Heart Journal. 36. 1068–1068. 1 indexed citations

Bahit, M. Cecilia, Renato D. Lópes, Daniel Wojdyla, et al.. (2015). Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation : insights from the ARISTOTLE trial. European Heart Journal. 36. 338–339. 3 indexed citations

Hijazi, Ziad, S. H. Hohnloser, Ulrika Andersson, et al.. (2015). Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation : Insights from the ARISTOTLE trial. European Heart Journal. 36. 339–339. 7 indexed citations

Christersson, Christina, Lars Wallentin, Ulrika Andersson, et al.. (2014). The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment. European Heart Journal. 35. 866–867. 1 indexed citations

Hijazi, Ziad, Johan Lindbäck, Agneta Siegbahn, et al.. (2014). A new biomarker based risk score for predicting major bleeding in atrial fibrillation - the ABC (age, biomarkers, current disease) risk score. European Heart Journal. 35. 357–357. 2 indexed citations

García, David, Daniel Wojdyla, Paul Dorian, et al.. (2013). Use of Apixaban and Warfarin in Patients Undergoing Invasive Procedures: Insights From Aristotle. Canadian Journal of Cardiology. 29(10). S232–S233. 4 indexed citations

10.

Held, Claes, John H. Alexander, Renato D. Lópes, et al.. (2013). Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial. European Heart Journal. 34(suppl 1). P536–P536. 1 indexed citations

11.

Ezekowitz, Justin A., Paul Dorian, C. B. Granger, et al.. (2011). 900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial. Canadian Journal of Cardiology. 27(5). S334–S334. 3 indexed citations

12.

Moliterno, David J., James J. Ferguson, Nathan R. Every, et al.. (2001). “Hot” Unstable Angina—Is it Worse than Subacute Unstable Angina? Results from the GUARANTEE Registry. Journal of Thrombosis and Thrombolysis. 12(3). 207–216. 1 indexed citations

13.

Patel, Anushka, Felix Zijlstra, Cindy L. Grines, et al.. (2000). Relation of time to treatment on relative effects of primary coronary angioplasty vs thrombolytic therapy. Heart Lung and Circulation. 9(3). A103–A103. 1 indexed citations

14.

Scirica, Benjamin M., David J. Moliterno, Nathan R. Every, et al.. (1999). Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry. American Heart Journal. 138(6). 1065–1072. 36 indexed citations

15.

Bart, Bradley A., Georg Ertl, Peter Held, et al.. (1999). Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. European Heart Journal. 20(16). 1182–1190. 81 indexed citations

16.

Hasdai, David, Amir Lerman, Charanjit S. Rihal, et al.. (1999). Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. American Heart Journal. 137(4). 612–620. 29 indexed citations

17.

White, H. D., C. B. Granger, Philip E. Aylward, et al.. (1998). Effects of four thrombolytic regimens in elderly patients. 15(1). 22–28. 1 indexed citations

18.

Feinglos, Mark N., et al.. (1997). Outcomes of Diabetic Patients Following Acute Myocardial Infarction: A Review of the Major Thrombolytic Trials. European Journal of Cardiovascular Prevention & Rehabilitation. 4(2). 100–111. 4 indexed citations

19.

Feinglos, Mark N., et al.. (1996). Outcomes of diabetic patients following acute myocardial infarction. Coronary Artery Disease. 7(10). 732–743. 22 indexed citations

20.

Krucoff, Mitchell W., Frank E. Harrell, Sharon Sawchak, et al.. (1994). From signal/noise to information content/noise. Journal of Electrocardiology. 27. 233–237. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact